Origins, Treatments, and Family Perspectives – Saturday, May 7, 2005

Borderline Personality Disorder:
Origins, Treatments, and Family Perspectives

Saturday, May 7, 2005
Mary S. Harkness Auditorium, New Haven, CT

---

Sponsored by:	The National Education Alliance for Borderline Personality Disorder (NEABPD) in partnership with the National Alliance for Research on Schizophrenia and Depression (NARSAD)
In cooperation with:	Yale-New Haven Psychiatric Hospital Department of Psychiatry, Yale University School of Medicine The National Alliance for the Mentally Ill-Connecticut
Conference Objectives	At the conclusion of the conference, attendees will be better able to identify, specify, and describe:1. The symptomatology of BPD 2. The current understanding of emotion dysregulation 3. The complexities of the diagnostic issues surrounding BPD 4. Issues of concern to consumers and family members 5. Research design elements and outcomes of a family program 6. The problems and options of medication programs for people with BPD 7. Three psychosocial treatment modalities
Course Description	The Conference is for physicians, psychiatrists, psychologists, social workers, family therapists, counselors, nurses, emergency room personnel, law enforcement personnel and agencies, family members, consumers, and educators. Continuing Education credits for social workers and Certificates of Attendance are also available upon request.
Statement of Need	Borderline Personality Disorder (BPD) is a severe and generally chronic disorder and people who suffer from it are underserved. Friends and families are often bewildered and do not know how to help. Treatment programs for those with BPD need to be more readily available. Families need access to programs such as those already developed for several other mental illnesses. BPD presents patients, their families and researchers with multiple challenges. These complex challenges will be addressed in order to inform mental health professionals, families, and consumers of the most current diagnostic and treatment options available, and other issues of current interest to those affected by the disorder.

Conference Program

Moderator for the day: Seth R. Axelrod, PhD

Welcome	Perry D. Hoffman, PhD The Mount Sinai School of Medicine President, NEABPDSeth R. Axelrod, PhD Assistant Professor of Psychiatry Intensive Outpatient Program DBT/DBT-S Team Leader Yale-New Haven Psychiatric Hospital Yale University School of Medicine
Opening Remarks	Benjamin S. Bunney, MD Charles B.G. Murphy Professor and Chairman of Psychiatry Professor of Pharmacology Yale University School of Medicine
Borderline Personality Disorder: What Is It?	Robert Stern, MD, PhD Associate Clinical Professor of Psychiatry Yale University School of Medicine
Biopsychology of Emotion Dysregulation	Rajita Sinha, PhD Associate Professor of Psychiatry Director, Research Program on Stress, Addiction and Psychopathology Director, Addiction Services Connecticut Mental Health Center Yale University School of Medicine
Disclosing the BPD Diagnosis: Practice and Recommendations	Richard G. Hersh, MD Assistant Clinical Professor of Psychiatry Columbia University College of Physicians and Surgeons Assistant Director of the Intensive Outpatient Program Columbia Presbyterian Medical Center
Family and Consumer Perspectives Panel, and Family Research	Dixianne Penney, Dr.PH Executive Vice-President, NEABPD Administrative Director Center for the Study of Issues in Public Health Nathan Kline Institute for Psychiatric ResearchPerry D. Hoffman, PhDEllie Buteau, PhD
Psychopharmacology of BPD: Benefits and Limitations	Kenneth R. Silk, MD Professor and Associate Chair Clinical and Administrative Affairs Department of Psychiatry University of Michigan Health System
Transference-Focused Psychotherapy	Frank E.Yeomans, MD, PhD Director of Training Personality Disorders Institute Clinical Associate Professor of Psychiatry Weill School of Medicine at Cornell University
Dialectical Behavior Therapy	George H. Davis, PhD Clinical Director Center for Dialectical and Cognitive Behavioral Therapies Assistant Clinical Professor of Psychiatry Yale University School of Medicine
Schema-Focused Therapy	Samuel A. Ball, PhD Associate Professor of Psychiatry Director of Training, NIDA Clinical Trials Network (New England Node) Director of Residential Services, APT Foundation Yale University School of Medicine Veterans Administration Connecticut Healthcare
Treatment Panel: Question and Answer Time